Page 1 | Search Results | Blood Advances | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis

Blood Adv (2024) 8 (7): 1772–1775.

https://doi.org/10.1182/bloodadvances.2023011426

Published: 2024

Includes: Supplemental data

Journal Articles

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

Amir Enshaei, Melvin Joy, Ellie Butler, Amy A. Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J. Harrison, Robin Foà, Josep-Maria Ribera, Sabina Chiaretti, Renato Bassan, Adele K. Fielding, Anthony V. Moorman

Blood Adv (2024) 8 (5): 1155–1166.

https://doi.org/10.1182/bloodadvances.2023011661

Published: 2024

Includes: Supplemental data

Journal Articles

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

Blood Adv (2023) 7 (15): 3862–3873.

https://doi.org/10.1182/bloodadvances.2022008992

Published: 2023

Includes: Supplemental data

Journal Articles

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria Marzolini, William Townsend, Maeve O'Reilly, Amy A. Kirkwood, Andrea Kuhnl

Blood Adv (2023) 7 (12): 2872–2883.

https://doi.org/10.1182/bloodadvances.2022009019

Published: 2023

Includes: Supplemental data

Journal Articles

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Blood Adv (2023) 7 (10): 2155–2165.

https://doi.org/10.1182/bloodadvances.2022009253

Published: 2023

Journal Articles

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

Andrea Kuhnl, Claire Roddie, Amy A. Kirkwood, Tobias Menne, Maria Cuadrado, Maria A. V. Marzolini, Wendy Osborne, Robin Sanderson, Maeve O’Reilly, William Townsend, Reuben Benjamin, Victoria Potter, Piers E. M. Patten, Deborah Yallop, Stefan Voo, George S. Petrides, Nicola Mulholland, Irfan Kayani

Blood Adv (2022) 6 (1): 321–326.

https://doi.org/10.1182/bloodadvances.2021005807

Published: 2022

Journal Articles

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

Rachel J. Mitchell, Amy A. Kirkwood, Emilio Barretta, Laura Clifton-Hadley, Emma Lawrie, SooWah Lee, Daniel Leongamornlert, David I. Marks, Andrew K. McMillan, Tobias F. Menne, Elli Papaemmanuil, Bela Patel, Pip Patrick, Clare J. Rowntree, Nahid Zareian, Krisztina Zuborne Alapi, Anthony V. Moorman, Adele K. Fielding

Blood Adv (2021) 5 (17): 3322–3332.

https://doi.org/10.1182/bloodadvances.2021004430

Published: 2021

Includes: Supplemental data

Journal Articles

Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP

Toby A. Eyre, William Wilson, Amy A. Kirkwood, Julia Wolf, Catherine Hildyard, Hannah Plaschkes, John Griffith, Paul Fields, Arief Gunawan, Rebecca Oliver, Stephen Booth, Jaimal Kothari, Christopher P. Fox, Nicolas Martinez-Calle, Andrew McMillan, Mark Bishton, Graham P. Collins, Chris S. R. Hatton

Blood Adv (2021) 5 (8): 2229–2236.

https://doi.org/10.1182/bloodadvances.2021004286

Published: 2021

Includes: Supplemental data

Journal Articles

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Blood Adv (2020) 4 (18): 4337–4346.

https://doi.org/10.1182/bloodadvances.2020002553

Published: 2020

Includes: Supplemental data

Journal Articles

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

Emma Das-Gupta, Kirsty J. Thomson, Adrian J. C. Bloor, Andrew D. Clark, Stephen Mackinnon, Irfan Kayani, Laura Clifton-Hadley, Pip Patrick, Nadjet El-Mehidi, Anthony Lawrie, Amy A. Kirkwood, Nigel H. Russell, David C. Linch, Karl S. Peggs

Blood Adv (2019) 3 (24): 4264–4270.

https://doi.org/10.1182/bloodadvances.2019001016

Published: 2019

Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Blood Adv (2019) 3 (10): 1568–1573.

https://doi.org/10.1182/bloodadvances.2019000180

Published: 2019

NARROW

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only